Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2005

01-09-2005 | Letter to the Editor

Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infection

Authors: Philip T. Murphy, Michael Fay, John Quinn, J. Rory O’Donnell

Published in: Annals of Hematology | Issue 9/2005

Login to get access

Abstract

We describe a case of blood transfusion-dependent myelodysplastic syndrome (refractory anaemia), associated with macrocytosis and elevated percentage of hypochromic cells. Following an acute hospital admission with a respiratory tract infection, the patient entered a complete and sustained remission.
Literature
1.
Maywald O, Buchheidt D, Bergmann J, Schoch C, Ludwig W-D, Reiter A, Hastka J, Lengfelder E, Hehlmann R (2004) Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature. Ann Hematol 83:189–194
2.
Wang H, Chuhjo T, Yamazaki H, Shiobara S, Teramura M, Mizoguchi H, Nakao S (2001) Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis. Eur J Haematol 66:200–205
3.
Broun ER, Heerema NA, Tricot G (1990) Spontaneous remission in myelodysplastic syndrome. A case report. Cancer Genet Cytogenet 46:125–128
4.
Petti MC, Latagliata R, Breccia M, Alimenta G, Spadea A, D’Andrea M, Mancini M, Spiriti MAA, Mandelli F (2001) Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event. Haematologica 86:1277–1280
5.
Renneboog B, Hansen V, Heimann P, De Mulder A, Janssen F, Ferster A (1996) Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 92:696–698
6.
Deharo S, Bizet M, Monconduit M, Tilly H, Sari F, Piguet H (1987) Spontaneous remission of refractory anemia with excess of blasts after septicemia. Ann Med Interne 138:663–664
7.
Dervenoulas JG, Tsirigotis P, Bollas G, Pappa V, Raptis S (1999) Spontaneous remission in myelodysplastic syndrome. Ann Hematol 78:89–90
8.
Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253–1259CrossRefPubMed
9.
Elghetany MT, Hudnal SD, Gardner FH (1997) Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis. Haematologica 82:21–24
10.
MacGibbon BH, Mollin DL (1965) Sideroblastic anaemia in man: observations on seventy cases. Br J Haematol 11:59–69
11.
Dacie JV, Smith MD, White JC, Mollin DL (1959) Refractory normoblastic anaemia: a clinical and haematological study of seven cases. Br J Haematol 5:56–82
Metadata
Title
Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infection
Authors
Philip T. Murphy
Michael Fay
John Quinn
J. Rory O’Donnell
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 9/2005
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-005-1017-5

Other articles of this Issue 9/2005

Annals of Hematology 9/2005 Go to the issue

Letter to the Editor

Durable complete remission after chemotherapy and rituximab in a case of Waldenström’s macroglobulinemia with pleuropulmonary involvement

Original Article

Correlations among serum leptin levels, complete blood count parameters and peripheral CD34(+) cell count in prepubertal obese children

Original Article

Expression of interferon-γ and tumor necrosis factor-α in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia

Original Article

A deletion of 11 bp (CD 131–134) in exon 3 of the β-globin gene produces the phenotype of inclusion body β-thalassemia

Original Article

Cyclosporin A in myelodysplastic syndrome: a preliminary report

Original Article

Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits